Genetic assessment of the importance of galectin-3 in cancer initiation, progression, and dissemination in mice

Isabelle Eude-le Parco, Gaëlle Gendronneau, Tien Dang, Delphine Delacour, Victor I. Thijssen, Winfried Edelmann, Michel Peuchmaur, Françoise Poirier

Research output: Contribution to journalArticle

27 Citations (Scopus)

Abstract

The galectin family of β-galactoside binding lectins is involved in normal and pathological processes. Altered expression of galectin-3 has been described in many cancers, and studies of cancer cell lines have implicated this lectin in various aspects of the tumorigenic cascade. The goal of this report was to directly assess the importance of galectin-3 in tumor biology by introducing the galectin-3 null mutation (galectin-3-/-) into mouse lines genetically programmed to develop cancers. We used two mouse models of human intestinal cancer, the ApcMin and Apc1638N lines, to study tumor initiation and tumor progression. We also crossed the galectin- 3-/- mice with PyMT transgenic animals, a model in which primary mammary gland tumors give rise to lung metastases at high frequency. Unexpectedly, we show that the absence of galectin-3 does not affect the evolution of the disease in any of these three situations.

Original languageEnglish (US)
Pages (from-to)68-75
Number of pages8
JournalGlycobiology
Volume19
Issue number1
DOIs
StatePublished - 2009

Fingerprint

Galectin 3
Tumors
Neoplasms
Lectins
Galectins
Intestinal Neoplasms
Galactosides
Genetically Modified Animals
Pathologic Processes
Human Mammary Glands
Animals
Animal Models
Cells
Breast Neoplasms
Neoplasm Metastasis
Cell Line
Lung
Mutation

Keywords

  • Apc mutations
  • Galectin-3 knock-out mice
  • Metastasis
  • PyMT transgenic
  • Tumor progression

ASJC Scopus subject areas

  • Biochemistry

Cite this

Eude-le Parco, I., Gendronneau, G., Dang, T., Delacour, D., Thijssen, V. I., Edelmann, W., ... Poirier, F. (2009). Genetic assessment of the importance of galectin-3 in cancer initiation, progression, and dissemination in mice. Glycobiology, 19(1), 68-75. https://doi.org/10.1093/glycob/cwn105

Genetic assessment of the importance of galectin-3 in cancer initiation, progression, and dissemination in mice. / Eude-le Parco, Isabelle; Gendronneau, Gaëlle; Dang, Tien; Delacour, Delphine; Thijssen, Victor I.; Edelmann, Winfried; Peuchmaur, Michel; Poirier, Françoise.

In: Glycobiology, Vol. 19, No. 1, 2009, p. 68-75.

Research output: Contribution to journalArticle

Eude-le Parco, I, Gendronneau, G, Dang, T, Delacour, D, Thijssen, VI, Edelmann, W, Peuchmaur, M & Poirier, F 2009, 'Genetic assessment of the importance of galectin-3 in cancer initiation, progression, and dissemination in mice', Glycobiology, vol. 19, no. 1, pp. 68-75. https://doi.org/10.1093/glycob/cwn105
Eude-le Parco, Isabelle ; Gendronneau, Gaëlle ; Dang, Tien ; Delacour, Delphine ; Thijssen, Victor I. ; Edelmann, Winfried ; Peuchmaur, Michel ; Poirier, Françoise. / Genetic assessment of the importance of galectin-3 in cancer initiation, progression, and dissemination in mice. In: Glycobiology. 2009 ; Vol. 19, No. 1. pp. 68-75.
@article{f2e89c93a190463d87ac4774e533a864,
title = "Genetic assessment of the importance of galectin-3 in cancer initiation, progression, and dissemination in mice",
abstract = "The galectin family of β-galactoside binding lectins is involved in normal and pathological processes. Altered expression of galectin-3 has been described in many cancers, and studies of cancer cell lines have implicated this lectin in various aspects of the tumorigenic cascade. The goal of this report was to directly assess the importance of galectin-3 in tumor biology by introducing the galectin-3 null mutation (galectin-3-/-) into mouse lines genetically programmed to develop cancers. We used two mouse models of human intestinal cancer, the ApcMin and Apc1638N lines, to study tumor initiation and tumor progression. We also crossed the galectin- 3-/- mice with PyMT transgenic animals, a model in which primary mammary gland tumors give rise to lung metastases at high frequency. Unexpectedly, we show that the absence of galectin-3 does not affect the evolution of the disease in any of these three situations.",
keywords = "Apc mutations, Galectin-3 knock-out mice, Metastasis, PyMT transgenic, Tumor progression",
author = "{Eude-le Parco}, Isabelle and Ga{\"e}lle Gendronneau and Tien Dang and Delphine Delacour and Thijssen, {Victor I.} and Winfried Edelmann and Michel Peuchmaur and Fran{\cc}oise Poirier",
year = "2009",
doi = "10.1093/glycob/cwn105",
language = "English (US)",
volume = "19",
pages = "68--75",
journal = "Glycobiology",
issn = "0959-6658",
publisher = "Oxford University Press",
number = "1",

}

TY - JOUR

T1 - Genetic assessment of the importance of galectin-3 in cancer initiation, progression, and dissemination in mice

AU - Eude-le Parco, Isabelle

AU - Gendronneau, Gaëlle

AU - Dang, Tien

AU - Delacour, Delphine

AU - Thijssen, Victor I.

AU - Edelmann, Winfried

AU - Peuchmaur, Michel

AU - Poirier, Françoise

PY - 2009

Y1 - 2009

N2 - The galectin family of β-galactoside binding lectins is involved in normal and pathological processes. Altered expression of galectin-3 has been described in many cancers, and studies of cancer cell lines have implicated this lectin in various aspects of the tumorigenic cascade. The goal of this report was to directly assess the importance of galectin-3 in tumor biology by introducing the galectin-3 null mutation (galectin-3-/-) into mouse lines genetically programmed to develop cancers. We used two mouse models of human intestinal cancer, the ApcMin and Apc1638N lines, to study tumor initiation and tumor progression. We also crossed the galectin- 3-/- mice with PyMT transgenic animals, a model in which primary mammary gland tumors give rise to lung metastases at high frequency. Unexpectedly, we show that the absence of galectin-3 does not affect the evolution of the disease in any of these three situations.

AB - The galectin family of β-galactoside binding lectins is involved in normal and pathological processes. Altered expression of galectin-3 has been described in many cancers, and studies of cancer cell lines have implicated this lectin in various aspects of the tumorigenic cascade. The goal of this report was to directly assess the importance of galectin-3 in tumor biology by introducing the galectin-3 null mutation (galectin-3-/-) into mouse lines genetically programmed to develop cancers. We used two mouse models of human intestinal cancer, the ApcMin and Apc1638N lines, to study tumor initiation and tumor progression. We also crossed the galectin- 3-/- mice with PyMT transgenic animals, a model in which primary mammary gland tumors give rise to lung metastases at high frequency. Unexpectedly, we show that the absence of galectin-3 does not affect the evolution of the disease in any of these three situations.

KW - Apc mutations

KW - Galectin-3 knock-out mice

KW - Metastasis

KW - PyMT transgenic

KW - Tumor progression

UR - http://www.scopus.com/inward/record.url?scp=57649207937&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=57649207937&partnerID=8YFLogxK

U2 - 10.1093/glycob/cwn105

DO - 10.1093/glycob/cwn105

M3 - Article

C2 - 18849326

AN - SCOPUS:57649207937

VL - 19

SP - 68

EP - 75

JO - Glycobiology

JF - Glycobiology

SN - 0959-6658

IS - 1

ER -